期刊文献+

左卡尼汀对柔红霉素所致心肌细胞损伤的保护作用 被引量:2

Protective effect of levocarnitine on daunorubicin-induced myocardial cell injury
下载PDF
导出
摘要 目的:观察左卡尼汀注射液(Levocarnitine injection)对柔红霉素(Daunorubicin,DNR)所致的心肌细胞损伤的保护作用。方法:将培养5d的新生Wister乳鼠心肌细胞随机分为正常对照组、DNR损伤组和左卡尼汀低、中、高剂量保护组,加药后继续培养24 h,测定细胞存活率、乳酸脱氢酶(LDH)释放量、超氧化物歧化酶(SOD)活性和丙二醛(MDA)含量。结果:左卡尼汀各实验剂量均能显著提高受损心肌细胞的存活率,抑制LDH释放量,减少MDA的生成,提高SOD活性。结论:左卡尼汀对柔红霉素所致的心肌细胞损伤具有保护作用。 Objective: This study aimed to determine the protective effect of levocarnitine on myocardial injury caused by daunorublcm (DNR). Methods: Neonatal cardiomyocytes (aged 5 days) from trained Wister rats were randomly divided into the following groups: normal control group, low DNR injury group, and levocamitine protection group. High-dose DNR was administered and the cardiomyocytes were cultured for 24 h. Cell viability, lactate dehydrogenase (LDH) release, superoxide dismutase (SOD) activity, and malondialdehyde (MDA) content were determined. Results: The levocarnitine dose could significantly improve the survival rate of damaged myocardial cells, inhibit LDH release, and reduce MDA production and SOD activity. Conclusion: Levocamitine exhibited a protective effect on DNRiamycin-induced myocardial cell injury.
作者 李雅静 王晨
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第4期195-197,共3页 Chinese Journal of Clinical Oncology
基金 2010年天津市卫生局科技基金项目(编号:2010KZ75)资助~~
关键词 左卡尼汀注射液 柔红霉素 心肌细胞 心脏毒性 levocamitine injection, daunorubicin, myocardial cells, cardiotoxicity
  • 相关文献

参考文献15

二级参考文献146

共引文献96

同被引文献30

  • 1陈大可,王娟.生脉注射液联合左卡尼汀对阿霉素化疗患者的心肌保护作用[J].实用癌症杂志,2014,29(3):349-351. 被引量:7
  • 2解丽君,张建新,李兰芳.异丙酚对大鼠离体心脏缺血再灌注损伤的保护作用[J].中华麻醉学杂志,2005,25(9):667-670. 被引量:11
  • 3云俊杰,吴士尧.蒽环类药物对心肌毒性的早期监测[J].国际心血管商杂志,2009,36(3):171--173. 被引量:1
  • 4Stfirba M, Popelovd O, Vdvrovd A, et al. Oxidative stress, redox signaling, and metal chelation in anthracydine cardiotoxicity and pharmacological cardioprotection[J]. Antioxid Redox Signal, 2013, 18(8) :899--929. 被引量:1
  • 5Octavia Y, Tocchetti CG, Gabrielson KL, et al. Doxorubicin--in- duced cardiomyopathy: from molecular mechanisms to therapeutic strategies[J].J Mol Cellular Cardiol, 2012, 52(6):1213-1225. 被引量:1
  • 6Sag CM, Kthler AC, Anderson ME, et al. CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes[J].J Mol Cell Cardiol, 2011, 51(5):749-759. 被引量:1
  • 7Cusack BJ, Gambliel H, Musser B, et al. Prevention of chronic an- thracycline cardiotoxicity in the adult Fischer 344 rat by dexrazox- ane and effects on iron metabolism[J]. Cancer Chemother Pharma- col, 2006, 58(4):517-526. 被引量:1
  • 8Broeyer FJ, Osanto S, Ritsema van Eck HJ, et al. Evaluation of bio- markers for cardiotoxicity of anthracyclin-based chemotherapy[J].J Cancer Res Clin Oncol, 2008, 134(9):961-968. 被引量:1
  • 9Dolci A, Dominci R, Cardinale D, et al. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic re- view of the fiterature and recommendations for use[J]. Am J Clin Pathol, 2008, 130(5):688-695. 被引量:1
  • 10Horacek JM, Pudil R, Jebavy L, et al. Assessment of anthracy- cline-induced cardiotoxicity with biochemical markers[J]. Exp Oncol, 2007, 29(4):309-313. 被引量:1

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部